These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 21854160

  • 1. Prevalence of caffeine use in elite athletes following its removal from the World Anti-Doping Agency list of banned substances.
    Del Coso J, Muñoz G, Muñoz-Guerra J.
    Appl Physiol Nutr Metab; 2011 Aug; 36(4):555-61. PubMed ID: 21854160
    [Abstract] [Full Text] [Related]

  • 2. Distribution of caffeine levels in urine in different sports in relation to doping control before and after the removal of caffeine from the WADA doping list.
    Van Thuyne W, Delbeke FT.
    Int J Sports Med; 2006 Sep; 27(9):745-50. PubMed ID: 16586337
    [Abstract] [Full Text] [Related]

  • 3. Urine Caffeine Concentration in Doping Control Samples from 2004 to 2015.
    Aguilar-Navarro M, Muñoz G, Salinero JJ, Muñoz-Guerra J, Fernández-Álvarez M, Plata MDM, Del Coso J.
    Nutrients; 2019 Jan 29; 11(2):. PubMed ID: 30699902
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Distribution of caffeine levels in urine in different sports in relation to doping control before and after the removal of caffeine from the WADA doping list.
    Kuipers H.
    Int J Sports Med; 2007 Feb 29; 28(2):178; author reply 178. PubMed ID: 17290310
    [No Abstract] [Full Text] [Related]

  • 6. Quantitative analysis of urinary glycerol levels for doping control purposes using gas chromatography-mass spectrometry.
    Thevis M, Guddat S, Flenker U, Schänzer W.
    Eur J Mass Spectrom (Chichester); 2008 Feb 29; 14(3):117-25. PubMed ID: 18708691
    [Abstract] [Full Text] [Related]

  • 7. A population study of urine glycerol concentrations in elite athletes competing in North America.
    Kelly BN, Madsen M, Sharpe K, Nair V, Eichner D.
    Drug Test Anal; 2013 Feb 29; 5(11-12):890-5. PubMed ID: 24353191
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of urine analysis and dried blood spot analysis for the detection of ephedrine and methylephedrine in doping control.
    Kojima A, Nishitani Y, Sato M, Kageyama S, Dohi M, Okano M.
    Drug Test Anal; 2016 Feb 29; 8(2):189-98. PubMed ID: 25869885
    [Abstract] [Full Text] [Related]

  • 11. Quantifying cobalt in doping control urine samples--a pilot study.
    Krug O, Kutscher D, Piper T, Geyer H, Schänzer W, Thevis M.
    Drug Test Anal; 2014 Feb 29; 6(11-12):1186-90. PubMed ID: 25044557
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interpretation of urinary concentrations of pseudoephedrine and its metabolite cathine in relation to doping control.
    Deventer K, Van Eenoo P, Baele G, Pozo OJ, Van Thuyne W, Delbeke FT.
    Drug Test Anal; 2009 May 29; 1(5):209-13. PubMed ID: 20355197
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence of illicit drug use among the Italian athlete population with special attention on drugs of abuse: a 10-year review.
    Strano Rossi S, Botrè F.
    J Sports Sci; 2011 Mar 29; 29(5):471-6. PubMed ID: 21279865
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Caffeine consumption amongst British athletes following changes to the 2004 WADA prohibited list.
    Chester N, Wojek N.
    Int J Sports Med; 2008 Jun 29; 29(6):524-8. PubMed ID: 18027309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.